Taliaz

Predictive Technology for Personalized Medication

Health Tech & Life Sciences
Active
Mature Tel Aviv-Yafo, Israel Founded 2012
Last updated 2026-06-18
Total raised
$3.2M
Last: Grant 2020-11
Stage
Mature
Founded
2012
Headcount
16
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Taliaz is the developer of Predictix, an AI-based branded platform designed to help doctors deliver personalized medicine. Based on proprietary IP, Predictix generates doctor-centric therapy prediction reports for individual patients. The Predictix reports are managed as a decision-support tool, enabling general practitioners and specialists to make informed treatment choices for improved patient outcomes. The companys flagship application addresses depression. The Predictix Anti-Depressant AI system is a noninvasive, user-friendly application that analyzes genomic, clinical, and demographic data to generate a personalized report that includes statistical analysis on the efficacy of antidepressants and their side effects, allowing doctors to optimize antidepressant treatment strategies for enhanced patient outcomes. The application is currently available for commercial use in the EU and Israel. Taliaz mission is to empower doctors and patients with artificial intelligence technology to improve the assessment, treatment, and management of mental health disorders.

Funding history · 2 rounds · $3.2M total

2020-11
Grant $2.7M
2015-12

Q&A

What is Taliaz's primary focus?
Taliaz develops Predictix, an AI-based platform designed to assist doctors in delivering personalized medicine, particularly for mental health disorders like depression.
What is the core technology behind Taliaz's Predictix platform?
The Predictix platform utilizes artificial intelligence and machine learning to analyze genomic, clinical, and demographic data to generate personalized therapy prediction reports.
In which regions is Taliaz's flagship application commercially available?
Taliaz's Predictix Anti-Depressant AI system is currently available for commercial use in the EU and Israel.
When was Taliaz founded?
Taliaz was founded in August 2012.
What was Taliaz's most recent funding round?
In November 2020, Taliaz received a Grant of $2,700,000.
Who are the co-founders of Taliaz?
The co-founders of Taliaz are Dekel Taliaz (Co-Founder & CEO) and Oren Taliaz (Co-Founder & CFO).
What is Taliaz's total funding raised to date?
Taliaz has raised a total of $3,200,000.

Team · 2

Founder · Co-Founder & CEO
LinkedIn ↗
Founder · Co-Founder & CFO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsLaboratoriesProvidersFinancial ServicesFinancial ProductsInsurance
Business model
B2B

Highlights

1 PatentsVerified

Tags

mental-healthnon-invasivediagnosticsdigital-healthcaredoctorsdrugs-managementbig-dataartificial-intelligencehealthcare-providersprecision-medicinepredictive-analyticsdecision-makingdata-analyticsmachine-learningpatientsdecision-supportinsurance-companiesalgorithmshospitalslaboratoriessoftware-development
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)